Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation
Part of paid clinical trials in Brooklyn, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT07203482
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 40 Years - 95 Years
- Healthy Volunteers
- Not accepted
Study Details
Many reports of clinical outcomes following treatment of localized prostate cancer suffer from lack of prospective long-term data using objective and validated outcome instruments. The purpose of this research database is to prospectively collect data to assess treatment related complications, oncologic outcomes and urinary/sexual function, and identify predictors of complications, oncological control and functional outcomes after Hhigh-intensity focused ultrasound (HIFU) ablation of prostate cancer with the intent to guide further research and improve patient care. We will include subjects who will have a HIFU procedure performed from all Sub-Investigators included in the study.
Key Dates
- Start date
- May 16, 2024
- Status verified
- Sep 2025
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2050
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Prostate Cancer Patients Scheduled for HIFU ProcedureParticipants will be actively followed up for the first 3 years. After that once a year for life, unless they withdraw from the study or no longer seek standard of care at NYU Langone Health.
Primary Outcome Measure
Change in Prostate-Specific Antigen (PSA) Levels [ Time Frame: Baseline (pre-HIFU ablation procedure), Month 3, Month 6, Month 12, Month 18, Month 24, Month 30, Month 48, Month 60 ]
Central Contacts
- Majlinda Tafa, MD(646) 825-6338
- James Wysock, MD(646) 825-6366
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NYU Langone Health - Cobble Hill | Brooklyn | New York | 11201 | - |
| NYU Langone Health - Tisch Hospital | New York | New York | 10016 | - |
Find similar trials in Brooklyn, NY
Related Studies
- [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate CancerRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer SurgeryRecruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · Recruiting · Astellas Pharma Global Development, Inc. · Anchorage, Alaska